FYI - For Your Innovation

Transforming Medicine with Dr. Agnieszka Czechowicz


Listen Later

Dr. Agnieszka Czechowicz is driven by her passion for making an impact and changing the way that care is provided. Throughout her career she has taken science and translated it into medicines, many of which are having helping patients. Agnieszka has worked with a wide range of companies, from those that do gene editing to those that focus on hearing and balance disorders. However, her main area of research is in the field of hematopoietic stem cells. In today’s episode, Agnieszka explains the importance of these cells, and the benefits of the hematopoietic stem cells transplants. Agnieszka’s interest in transplant medicine began at a young age, and her passion for the field continues to grow year after year. Tune in today to hear about how Agnieska is contributing to the transformation of the medical field!

“We showed that your own stem cells compete for space with the transplanted stem cells in a hematopoietic stem cell transplantation process.” — @aneeshka
Key Points from this Episode
  • An overview of Dr. Agnieszka Czechowicz’s incredible career.
  • Where Agnieszka’s interest in transplant medicine originated.
  • What keeps Agnieszka motivated, despite the challenges of being a physician scientist.
  • The power of hematopoietic stem cells.
  • An explanation of the two bone marrow failure syndromes that Agnieszka specializes in.
  • Discoveries that Agnieszka made many years ago when conducting research into hematopoietic stem cell transplantation.
  • Problems with the genotoxic conditioning that is used prior to bone marrow and hematopoietic stem cell transplants.
  • The mission of Magenta Therapeutics, of which Agnieszka is a co-founder.
  • Feedback on progress that Magenta Therapeutics is making.
  • The potentially transformative power of agent CD117 ADC.
  • How agents developed by Magenta Therapeutics can be used in gene editing and gene therapy.
  • Agnieszka’s involvement with Jasper Therapeutics, and the therapy that they are currently working on.
  • Interventions that Agnieszka believes will cause a profound reduction in graft versus host diseases.
  • Work that Agnieszka has done for Third Rock Ventures.
  • Some of bluebird bio’s achievements and setbacks.
  • Agnieszka’s involvement with Editas, Decibel Therapeutics, and Beam Therapeutics (and where the name Beam came from).
  • Ex vivo versus in vivo manipulation techniques.
  • What drives Agnieskza to do the work that she does.
  • Agnieszka’s passion for women’s health.
  • ...more
    View all episodesView all episodes
    Download on the App Store

    FYI - For Your InnovationBy ARK Invest

    • 4.7
    • 4.7
    • 4.7
    • 4.7
    • 4.7

    4.7

    388 ratings


    More shows like FYI - For Your Innovation

    View all
    We Study Billionaires - The Investor’s Podcast Network by The Investor's Podcast Network

    We Study Billionaires - The Investor’s Podcast Network

    3,372 Listeners

    This Week in Startups by Jason Calacanis

    This Week in Startups

    1,281 Listeners

    The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch by Harry Stebbings

    The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

    534 Listeners

    Masters in Business by Bloomberg

    Masters in Business

    2,170 Listeners

    The a16z Show by Andreessen Horowitz

    The a16z Show

    1,094 Listeners

    The Meb Faber Show - Better Investing by The Idea Farm

    The Meb Faber Show - Better Investing

    946 Listeners

    Unchained by Laura Shin

    Unchained

    1,205 Listeners

    Azeem Azhar's Exponential View by Azeem Azhar

    Azeem Azhar's Exponential View

    614 Listeners

    Real Vision: Finance & Investing by Real Vision Podcast Network

    Real Vision: Finance & Investing

    904 Listeners

    The Intrinsic Value Podcast - The Investor’s Podcast Network by The Investor's Podcast Network

    The Intrinsic Value Podcast - The Investor’s Podcast Network

    561 Listeners

    All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

    All-In with Chamath, Jason, Sacks & Friedberg

    10,024 Listeners

    The Memo by Howard Marks by Oaktree Capital Management

    The Memo by Howard Marks

    453 Listeners

    No Priors: Artificial Intelligence | Technology | Startups by Conviction

    No Priors: Artificial Intelligence | Technology | Startups

    131 Listeners

    BG2Pod with Brad Gerstner and Bill Gurley by BG2Pod

    BG2Pod with Brad Gerstner and Bill Gurley

    474 Listeners

    AI + a16z by a16z

    AI + a16z

    35 Listeners